About 12 years.
Yes, it's common for a CR to be accompanied by a corporate presentation. Particularly when there's a retail component.
But it's uncommon for a a CR to accompany a corporate presentation. Over the last two years Resapp have done five presentations (excluding AGM presentations) and raised capital only once.
So while it's possible that a capital raising might be conducted – we are down to the last $3 million (3 quarters of normal funding) – there's nothing in this particular presentation that presages one. Nor is there anything in the results just released that would require a large injection of funds. The algorithm is already trained. Candidates will be easily available for a clinical trial. The testing required for the independent diagnosis is fast and inexpensive. Resapp already has a platform for delivering the product to individual users, corporations and medical practitioners.
- Forums
- ASX - By Stock
- Ann: COVID-19 Investor Presentation
About 12 years.Yes, it's common for a CR to be accompanied by a...
-
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
|
|||||
Last
20.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $176.2M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
RAP (ASX) Chart |
Day chart unavailable
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
Previous Video
Next Video
SPONSORED BY The Market Online